Celon Pharma

CLN · GPW · Poland

Public Market Listing

CLNGPW

GPW primary exchange listing

Live quotes, historical charts, and market capitalization for Celon Pharma are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
3Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
CPL207280No recent activity
Phase 2
GPR40 / FFAR1Small molecule
Type 2 Diabetes
Phase 2
PDE10ASmall molecule
Parkinson's DiseaseSchizophrenia

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (5 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$65M——$21Mreport ↗
View 4 more years
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$52M——$8.7Mreport ↗
2023-FY$52M——$6.7Mreport ↗
2022-FY$44M——$8.8Mreport ↗
2021-FY$52M——$3.0Mreport ↗